ARTICLE | Company News
Eurospital S.p.A., Hycor deal
August 1, 2011 7:00 AM UTC
Eurospital granted Hycor non-exclusive rights outside of the U.S. and Canada to Eurospital's transglutaminase 2 biomarker for use in assays to diagnose celiac disease. Eurospital will be eligible for...